261 related articles for article (PubMed ID: 31156702)
1. Whole-Exome Sequencing Identifies Somatic Mutations Associated With Mortality in Metastatic Clear Cell Kidney Carcinoma.
Mendoza-Alvarez A; Guillen-Guio B; Baez-Ortega A; Hernandez-Perez C; Lakhwani-Lakhwani S; Maeso MD; Lorenzo-Salazar JM; Morales M; Flores C
Front Genet; 2019; 10():439. PubMed ID: 31156702
[TBL] [Abstract][Full Text] [Related]
2. Somatic mutations in renal cell carcinomas from Chinese patients revealed by whole exome sequencing.
Wang J; Xi Z; Xi J; Zhang H; Li J; Xia Y; Yi Y
Cancer Cell Int; 2018; 18():159. PubMed ID: 30349421
[TBL] [Abstract][Full Text] [Related]
3. Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy.
Reustle A; Di Marco M; Meyerhoff C; Nelde A; Walz JS; Winter S; Kandabarau S; Büttner F; Haag M; Backert L; Kowalewski DJ; Rausch S; Hennenlotter J; Stühler V; Scharpf M; Fend F; Stenzl A; Rammensee HG; Bedke J; Stevanović S; Schwab M; Schaeffeler E
Genome Med; 2020 Mar; 12(1):32. PubMed ID: 32228647
[TBL] [Abstract][Full Text] [Related]
4. Whole-transcriptome sequencing identified gene expression signatures associated with aggressive clear cell renal cell carcinoma.
Batai K; Imler E; Pangilinan J; Bell R; Lwin A; Price E; Milinic T; Arora A; Ellis NA; Bracamonte E; Seligmann B; Lee BR
Genes Cancer; 2018 May; 9(5-6):247-256. PubMed ID: 30603059
[TBL] [Abstract][Full Text] [Related]
5. An integrative genomics approach for identifying novel functional consequences of PBRM1 truncated mutations in clear cell renal cell carcinoma (ccRCC).
Wang Y; Guo X; Bray MJ; Ding Z; Zhao Z
BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):515. PubMed ID: 27556922
[TBL] [Abstract][Full Text] [Related]
6. Intrinsic Genomic Differences Between African American and White Patients With Clear Cell Renal Cell Carcinoma.
Krishnan B; Rose TL; Kardos J; Milowsky MI; Kim WY
JAMA Oncol; 2016 May; 2(5):664-667. PubMed ID: 27010573
[TBL] [Abstract][Full Text] [Related]
7. Genomic Landscape of Chinese Clear Cell Renal Cell Carcinoma Patients With Venous Tumor Thrombus Identifies Chromosome 9 and 14 Deletions and Related Immunosuppressive Microenvironment.
Niu S; Liu K; Xu Y; Peng C; Yu Y; Huang Q; Wu S; Cui B; Huang Y; Ma X; Zhang X; Wang B
Front Oncol; 2021; 11():646338. PubMed ID: 34249685
[TBL] [Abstract][Full Text] [Related]
8. Somatic mutation profiles of clear cell endometrial tumors revealed by whole exome and targeted gene sequencing.
Le Gallo M; Rudd ML; Urick ME; Hansen NF; Zhang S; ; Lozy F; Sgroi DC; Vidal Bel A; Matias-Guiu X; Broaddus RR; Lu KH; Levine DA; Mutch DG; Goodfellow PJ; Salvesen HB; Mullikin JC; Bell DW
Cancer; 2017 Sep; 123(17):3261-3268. PubMed ID: 28485815
[TBL] [Abstract][Full Text] [Related]
9. Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.
Beltran H; Eng K; Mosquera JM; Sigaras A; Romanel A; Rennert H; Kossai M; Pauli C; Faltas B; Fontugne J; Park K; Banfelder J; Prandi D; Madhukar N; Zhang T; Padilla J; Greco N; McNary TJ; Herrscher E; Wilkes D; MacDonald TY; Xue H; Vacic V; Emde AK; Oschwald D; Tan AY; Chen Z; Collins C; Gleave ME; Wang Y; Chakravarty D; Schiffman M; Kim R; Campagne F; Robinson BD; Nanus DM; Tagawa ST; Xiang JZ; Smogorzewska A; Demichelis F; Rickman DS; Sboner A; Elemento O; Rubin MA
JAMA Oncol; 2015 Jul; 1(4):466-74. PubMed ID: 26181256
[TBL] [Abstract][Full Text] [Related]
10. Identification of Survival-Specific Genes in Clear Cell Renal Cell Carcinoma Using a Customized Next-Generation Sequencing Gene Panel.
Hwang J; Kim H; Han J; Lee J; Hong S; Kim S; Yoon SK; Choi K; Yang J; Park U; Kim K; Yim K; Kim Y; Choi Y
J Pers Med; 2022 Jan; 12(1):. PubMed ID: 35055428
[TBL] [Abstract][Full Text] [Related]
11. Identification of genes and pathways involved in kidney renal clear cell carcinoma.
Yang W; Yoshigoe K; Qin X; Liu JS; Yang JY; Niemierko A; Deng Y; Liu Y; Dunker A; Chen Z; Wang L; Xu D; Arabnia HR; Tong W; Yang M
BMC Bioinformatics; 2014; 15 Suppl 17(Suppl 17):S2. PubMed ID: 25559354
[TBL] [Abstract][Full Text] [Related]
12. Integrated genomic analysis identifies subclasses and prognosis signatures of kidney cancer.
Christinat Y; Krek W
Oncotarget; 2015 Apr; 6(12):10521-31. PubMed ID: 25826081
[TBL] [Abstract][Full Text] [Related]
13. The genomic landscape of metastatic clear cell renal cell carcinoma after systemic therapy.
van der Mijn JC; Eng KW; Chandra P; Fernandez E; Ramazanoglu S; Sigaras A; Oromendia C; Gudas LJ; Tagawa ST; Nanus DM; Faltas BF; Beltran H; Sternberg CN; Elemento O; Sboner A; Mosquera JM; Molina AM
Mol Oncol; 2022 Jun; 16(12):2384-2395. PubMed ID: 35231161
[TBL] [Abstract][Full Text] [Related]
14. Exome-wide Sequencing Shows Low Mutation Rates and Identifies Novel Mutated Genes in Seminomas.
Cutcutache I; Suzuki Y; Tan IB; Ramgopal S; Zhang S; Ramnarayanan K; Gan A; Lee HH; Tay ST; Ooi A; Ong CK; Bolthouse JT; Lane BR; Anema JG; Kahnoski RJ; Tan P; Teh BT; Rozen SG
Eur Urol; 2015 Jul; 68(1):77-83. PubMed ID: 25597018
[TBL] [Abstract][Full Text] [Related]
15. Genomic Characterization of Renal Cell Carcinoma with Sarcomatoid Dedifferentiation Pinpoints Recurrent Genomic Alterations.
Malouf GG; Ali SM; Wang K; Balasubramanian S; Ross JS; Miller VA; Stephens PJ; Khayat D; Pal SK; Su X; Sircar K; Tamboli P; Jonasch E; Tannir NM; Wood CG; Karam JA
Eur Urol; 2016 Aug; 70(2):348-57. PubMed ID: 26895810
[TBL] [Abstract][Full Text] [Related]
16. Exome-wide analysis of bi-allelic alterations identifies a Lynch phenotype in The Cancer Genome Atlas.
Buckley AR; Ideker T; Carter H; Harismendy O; Schork NJ
Genome Med; 2018 Sep; 10(1):69. PubMed ID: 30217226
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological and prognostic impact of somatic mutations in Chinese patients with clear cell renal cell carcinoma.
Bi H; Yin J; Zhou L; Wu Y; Ge L; Lu M; Liu L; Zhang H; Zhao Y; Liu C; Ma L
Transl Androl Urol; 2020 Dec; 9(6):2751-2763. PubMed ID: 33457247
[TBL] [Abstract][Full Text] [Related]
18. Differential gene expression profiling of matched primary renal cell carcinoma and metastases reveals upregulation of extracellular matrix genes.
Ho TH; Serie DJ; Parasramka M; Cheville JC; Bot BM; Tan W; Wang L; Joseph RW; Hilton T; Leibovich BC; Parker AS; Eckel-Passow JE
Ann Oncol; 2017 Mar; 28(3):604-610. PubMed ID: 27993815
[TBL] [Abstract][Full Text] [Related]
19. Construction and Validation of an Autophagy-Related Prognostic Risk Signature for Survival Predicting in Clear Cell Renal Cell Carcinoma Patients.
Yang H; Han M; Li H
Front Oncol; 2020; 10():707. PubMed ID: 32432045
[No Abstract] [Full Text] [Related]
20. Genomic characterization of clear cell renal cell carcinoma using targeted gene sequencing.
Lin PH; Huang CY; Yu KJ; Kan HC; Liu CY; Chuang CK; Lu YC; Chang YH; Shao IH; Pang ST
Oncol Lett; 2021 Feb; 21(2):169. PubMed ID: 33456545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
